Study of ALE.C04 in Patients With Head and Neck Cancer

Clinical trial NCT06054477 · TERMINATED

Trial details

NCT number: NCT06054477
Sponsor: Alentis Therapeutics AG
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2023-10-30
Primary completion: 2025-02-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.